NUVISAN The Science CRO
- Daniel Korr
Daniel Korr
Head Of Therapeutic Compound Research Laboratory, Principle Scientist at NUVISAN The Science CRO
Daniel Korr is currently the Head of Therapeutic Compound Research Laboratory at NUVISAN The Science CRO. Prior to this, Daniel held various positions at Bayer, including as Head of Oncology Research Laboratory. Daniel has a Ph.D. in Biochemistry from Schering AG and has a strong background in oncology research.
Org chart
Sign up to view 0 direct reports
Get started